Samumed
Toggle navigation
Company
Culture
Team
Technology
Pipeline
Publications
Media
Español
Health Through
Regeneration
LEARN MORE
Samumed Receives Orphan Drug Designation from FDA for SM04646 as a Treatment for Idiopathic Pulmonary Fibrosis (IPF)
Samumed Successfully Completes Phase 1 Study for Potential Topical Treatment for Chronic Tendinopathy
Samumed and IHS Markit Present Analysis of Medicare Claims Data for Knee OA